methadone hydrochloride molteni 1 mg/ml syrop
l.molteni & c. dei f.lii alitti societa di esercizio s.p.a. - methadoni hydrochloridum - syrop - 1 mg/ml
dutasteride + tamsulosin hydrochloride león farma 0,5 mg + 0,4 mg kapsułki twarde
laboratorios leon farma, s.a. - dutasteridum + tamsulosini hydrochloridum - kapsułki twarde - 0,5 mg + 0,4 mg
ipidacrine hydrochloride grindeks 20 mg tabletki
as grindeks - ipidacrini hydrochloridum monohydricum - tabletki - 20 mg
ipidacrine hydrochloride grindeks 5 mg/ml roztwór do wstrzykiwań
as grindeks - ipidacrini hydrochloridum monohydricum - roztwór do wstrzykiwań - 5 mg/ml
ipidacrine hydrochloride grindeks 15 mg/ml roztwór do wstrzykiwań
as grindeks - ipidacrini hydrochloridum monohydricum - roztwór do wstrzykiwań - 15 mg/ml
vildagliptin + metformin hydrochloride +pharma 50 mg + 850 mg tabletki powlekane
+pharma arzneimittel gmbh - vildagliptinum + metformini hydrochloridum - tabletki powlekane - 50 mg + 850 mg
vildagliptin + metformin hydrochloride +pharma 50 mg + 1000 mg tabletki powlekane
+pharma arzneimittel gmbh - vildagliptinum + metformini hydrochloridum - tabletki powlekane - 50 mg + 1000 mg
sitagliptin + metformin hydrochloride tzf 50 mg + 1000 mg tabletki powlekane
tarchomińskie zakłady farmaceutyczne "polfa" s.a. - sitagliptini hydrochloridum monohydricum + metformini hydrochloridum - tabletki powlekane - 50 mg + 1000 mg
sitagliptin + metformin hydrochloride tzf 50 mg + 850 mg tabletki powlekane
tarchomińskie zakłady farmaceutyczne "polfa" s.a. - sitagliptini hydrochloridum monohydricum + metformini hydrochloridum - tabletki powlekane - 50 mg + 850 mg
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - вилдаглиптин, metformina chlorowodorek - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 i 5. 1 dla dostępnych danych o różnych kombinacjach).